MAGE-TAB Version 1.1 Comment[MetaboBank accession] MTBKS263 Study Title Associations of Metabolome-Derived Metabolites and Lipoprotein (sub)Classes with Multiple Intermediate Phenotypes in Japanese: The Nagahama Study Study Description To identify plasma biomarkers potentially predicting chronic diseases we used 1H nuclear magnetic resonance (NMR) metabolomics to test associations between 18 known metabolites and 111 lipoprotein constituents and 944 phenotypes determined in 302 healthy participants of the Nagahama Study. Experimental Design population based design Experimental Factor Name Experimental Factor Type Person Last Name Ou Matsuda Gauguier Person First Name Huiting Fumihiko Dominique Person Mid Initials Person Affiliation Center for Genomic Medicine, Graduate School of Medicine, Kyoto University Center for Genomic Medicine, Graduate School of Medicine, Kyoto University University Paris Cite, CNRS UMR 8251, Paris, France Person Roles submitter submitter submitter PubMed ID Publication DOI Protocol Name Sample collection Extraction NMR sample NMR spectroscopy NMR assay Data processing Metabolite identification Protocol Type Sample collection Extraction NMR sample NMR spectroscopy NMR assay Data processing Metabolite identification Protocol Description Blood samples were collected on EDTA coated tubes and plasma was separated by centrifugation. All plasma samples remained stored at -80°C until the day of analysis, when they were thawed on ice and kept at +4°C throughout the sample preparation and spectroscopy processing. NMR samples were prepared using a Gilson robot system for liquid handling with integrated temperature control. Study and QC samples were prepared as a mixture of plasma (225μL) and an equivalent volume of phosphate buffer (75 mM Na2HPO4, 2 mM NaN3, 4.6 mM sodium trimethylsilyl propionate-[2,2,3,3-2H4] (TSP) in H2O/D2O 4:1, pH 7.4 ± 0.1). Samples were transferred into 5 mm outer diameter SampleJet NMR tubes (Bruker, Rheinstetten, Germany) and then stored at 5 °C inside the SampleJet automatic sample changer until measurement (<24 h). Experimental procedures followed the recommendations for in vitro analytical and diagnostic procedures NMR samples were prepared using a Gilson robot system for liquid handling with integrated temperature control. Study and QC samples were prepared as a mixture of plasma (225μL) and an equivalent volume of phosphate buffer (75 mM Na2HPO4, 2 mM NaN3, 4.6 mM sodium trimethylsilyl propionate-[2,2,3,3-2H4] (TSP) in H2O/D2O 4:1, pH 7.4 ± 0.1). Samples were transferred into 5 mm outer diameter SampleJet NMR tubes (Bruker, Rheinstetten, Germany) and then stored at 5 °C inside the SampleJet automatic sample changer until measurement (<24 h). Experimental procedures followed the recommendations for in vitro analytical and diagnostic procedures. All data were acquired on a Bruker Avance III HD 600 MHz NMR spectrometer equipped with an In Vitro Diagnostics Research (IVDr) platform, a 5-mm TXI (inverse triple resonance) Z gradient probe with automated tuning and matching, and a SampleJet for refrigerated sample storage and preheating prior to automated data acquisition using Topspin 3.5pl7 and IconNMR v5.0.8 software (Bruker, Rheinstetten, Germany). The temperature was set to 310.00K ± 0.05 and verified with a 4 % methanol in 99.8 % methanol-d4 sample. The magnetic field homogeneity and the H2O signal offset (O1) were verified with a 2 mM sucrose sample with 2 mM NaN3 and 0.5mM sodium trimethylsilylpropanesulfonate (DSS) in 10 % D2O at 40 mm filling. A third QuantRefC reference sample (H144519_01, Bruker, Rheinstetten, Germany) was used to verify the stability of the signal intensities and recalibration was performed using the pulse length-based concentration (PULCON) determination principle when needed. To allow comparisons with other 1H NMR studies applying equivalent standardized methods, all experiments followed Bruker's IVDr standard operational procedures To allow comparisons with other 1H NMR studies applying equivalent standardized methods, all experiments followed Bruker's IVDr standard operational procedures The Bruker IVDr B.I. QUANT-PSTM quantification algorithm and the B.I. LISATM method were designed to quantify 41 plasma low molecular weight metabolites and lipoprotein parameters. A total of 112 lipoprotein parameters were quantified, whereas only 28 metabolites could be detected and quantified in plasma Protocol Parameters Extraction method NMR tube type;Solvent;Sample pH;Temperature Instrument;NMR probe;Number of transients;Pulse sequence name;Magnetic field strength Protocol Hardware Protocol Software Public Release Date 2025-06-12 Term Source Name Term Source File Term Source Version SDRF File MTBKS263.sdrf.txt Comment[Study type] blood metabolite profiling Comment[Experiment type] nuclear magnetic resonance spectroscopy Comment[Submission type] NMR Comment[BioProject] PRJDB20611 Comment[Related study] Comment[Contributor] Comment[Submission Date] 2025-05-19 Comment[Last Update Date] 2025-06-12